BASELINE ASSESSMENT OF CHLAMYDIA REINFECTION IN REGION VIII FAMILY PLANNING CLINICS FOR 2004-2005 Hamby, Y, JSI Research & Training Institute Donovan,

Slides:



Advertisements
Similar presentations
Repeat Infections among Adolescents and Young Adults: Findings From Philadelphia STD Clinics Nicole Liddon, PhD 1 Michael Eberhart, BS 2 Jami Leichliter,
Advertisements

Assessment of Chlamydia Rescreening Practices Kelly Opdyke, MPH Region II IPP Advisory Committee Mtg May 16-17, 2007 Cicatelli Associates Inc.
How to Measure the Effectiveness of the IPP (and all the CT Screening being done)? **Reduce Infertility** Ultimate Goal Reduce PID Reduce Chlamydia Prevalence.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
Impact of a Targeted Provider Intervention to Improve Chlamydia Screening Practices in a Large California Family Planning Program Joan M. Chow 1, MPH,
The Relationship Between Repeat Infections and Behavioral Risk Factors and Clinician Counseling: Findings from a Philadelphia STD Clinic M. Eberhart 1,
Revision of Region II IPP Screening Criteria May 16, 2007 Region II IPP Advisory Committee Meeting Cicatelli Associates Inc. New York City.
Epidemiology of Chlamydia in the United States Debra J. Mosure, Ph.D. Division of STD Prevention Centers for Disease Control and Prevention March 8, 2004.
SOUTH CAROLINA EPIDEMIOLOGIC PROFILE Data available in an Integrated Epidemiologic Profile Core Epi Section Socio-demographic characteristics of.
Once Is Not Enough: Re-screening Sexually Transmitted Disease (STD) Clinic Patients in Six Months to Detect New STDs Once Is Not Enough: Re-screening Sexually.
Repeat Chlamydial Infections in Region III Family Planning Clinics: Implications for Screening Programs Pamela G. Nathanson, Family Planning Council, Inc.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
Risk factors for Incident Trichomonas vaginalis among Women Recruited in RESPECT-2, an HIV Prevention Trial D Helms 1, D Mosure 1, T Peterman 1, C Metcalf.
Evaluation of Gonorrhea Screening in Family Planning Settings: California 2000 CK Kent, M Brammeier, G Bolan, N Casas, M Funabiku, P Blackburn Region IX.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 1998 Division of STD Prevention.
Using Test Kit Allotments to Reduce Chlamydia Screening in Low Risk Females for Re-allocation to Higher Risk Populations and Higher Yield Venues Rabins.
STD Knowledge and Practices of New York City Providers Meighan E. Rogers, MPH Bureau of STD Control, NYC DOHMH Region II IPP Meeting, May 31-June 1, 2006.
Analysis of Chlamydia Re-testing Rates Massachusetts Family Planning Update.
Infertility Prevention Project Region I June 1, 2009 Wells Beach, Maine Infertility Prevention Project Region I June 1, 2009 Wells Beach, Maine Steven.
Application of an Epi Profile: Gonorrhea in the U.S. Region V Gonorrhea Control Meeting.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2003 Division of STD Prevention.
Targeting Gonorrhea Counseling and Sex Partner Services to African Americans Using Zip Codes and Fee-for-Service Reimbursement National Coalition of STD.
Re-Screening of CT Positive Clients in Region X IPP, Goldenkranz S., 1 Fine D. 1 1 Center for Health Training 2010 CDC STD Prevention Meeting,
Sexually Transmitted Disease (STD) Surveillance Report, 2009 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Trends in Clinic Visits and Diagnosed C. trachomatis and N. gonorrhoeae Infections Following the Introduction of a Co-Pay in an STD Clinic C. Rietmeijer.
Region I IPP Clinic Staff and Provider Assessment Kim Watson, Jennifer Kawatu.
US Virgin Islands IPP: Use of Limited Resources Taetia Phillips-Dorsett, MS Territorial Director, USVI DOH STD/HIV/TB Program Region II IPP Advisory Meeting.
Chlamydial Infections in the U.S. Steven J Shapiro CCID/NCSHHSTP/DSTDP/PTB Region I Infertility Prevention Project Wells Beach, Maine June 2, 2009 Disclaimer:
2011 STD Surveillance Update. Successful Prevention of STDs Est. 19 million STIs in the U.S. each year costing $12 - $20 billion in lifetime direct medical.
GC Outbreak in Philadelphia Greta Anschuetz, MPH Philadelphia Department of Public Health
Pilot Study: Re-screening Adolescent and Young Adult Women for Chlamydia Infection Alison Muse NYSDOH Bureau of STD Control Region II IPP meeting November.
Utilization of Cross-matching Databases to Obtain Chlamydia Re-screening and Re-infection Rates for Family Planning/Infertility Prevention Project Clinics:
Region II IPP Data & Infrastructure Performance Measures Kelly Opdyke, MPH Region II IPP Advisory Committee Mtg May 16-17, 2007 Cicatelli Associates Inc.
Region I Infertility Prevention Project June 9-10, 2008 Wells Beach, Maine Steven J. Shapiro Infertility Prevention Project Coordinator CDC/CCID/NCHHSTP/DSTDP/PTB.
Sexually Transmitted Disease (STD) Surveillance Report, 2013 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 1998 Division of STD Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
Infrastructure Update Jennifer Kawatu Kim Watson Andee Krasner
SOUTH CAROLINA EPIDEMIOLOGIC PROFILE What is the Epi Profile? The HIV/AIDS Epidemiologic Profile is a document that: Describes the HIV/AIDS epidemic.
Targeting Chlamydia Screening Resources Region II IPP Advisory Meeting May 31, 2006 Kelly Opdyke, MPH Cicatelli Associates Inc.
Reaching Adolescents Michigan’s Infertility Prevention Screening Project.
Predicting Pregnancy Risk among Women Attending an STD Clinic Judith Shlay MD, MSPH Denver Public Health September 21, 2008 CityMatCH Conference.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 1999 Division of STD Prevention.
Philadelphia High School STD Screening Program Declining Disease Prevalence After 4 Years of Screening Lenore Asbel, Melinda Salmon, C. Victor Spain, Christa.
STD’s in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2001 Division of STD Prevention.
Increasing Incidence of Gonorrhea in California (the talk formerly known as: “Gonorrhea Drips on in California”) Michael C Samuel 1, Virginia Loo 1, Denise.
Focus Area 25 Sexually Transmitted Diseases Progress Review July 21, 2004.
Region I IPP Data Presentation Advisory Board Meeting June 2008 Wells, ME.
Expedited Partner Therapy The Denver Experience Cornelis A. Rietmeijer, MD, PhD Denver Public Health Department.
STDs in Racial and Ethnic Minorities Sexually Transmitted Disease Surveillance 2003 Division of STD Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2005 Division of STD Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2004 Division of STD Prevention.
Chlamydia Screening in Indian Country Regional Role in Promoting and Supporting Stop Chlamydia Project Activities Yvonne Hamby, MPH Region VIII Infertility.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
Region II Infertility Prevention Project Advisory Committee May 16-17, 2007 New York, New York Steven J. Shapiro Infertility Prevention Project Coordinator.
IPP Infrastructure Measures of Effectiveness: Preliminary Data and Next Steps Kelly Morrison Opdyke, MPH Region II Infertility Prevention Project Cicatelli.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
Region I IPP Advisory Board Meeting June 14 and 15, 2010 Wells, ME Chlamydia Testing during Pregnancy Test Only (PTO) Visits.
It's not what you know, but who you know: Risk factors for re-infection in the Philadelphia High School STD Screening Program Jennifer Beck, MPH APHA.
Cost of Screening Outside of IPP Chlamydia Screening Guidelines
Martin Goldberg1, Daniel R. Newman2, TA Peterman2,
Steven J. Shapiro Infertility Prevention Project Coordinator
Family Planning & STDP Brainstorming
Region I IPP Data Update Region I IPP Advisory Board Meeting
M Javanbakht, S Guerry, LV Smith, P Kerndt
Region I IPP Data Update Region I IPP Advisory Board Meeting
2008 National STD Prevention Conference Chicago, Illinois
Region II IPP Performance Measure IPP CS1 and IPP CS2 Project Area Trend Report IPP CS1: Timely treatment of women with chlamydia at IPP Family Planning.
Region I IPP Data Update Region I IPP Advisory Board Meeting
Gonorrhea Screening: What Do the Data Tell Us?
Presentation transcript:

BASELINE ASSESSMENT OF CHLAMYDIA REINFECTION IN REGION VIII FAMILY PLANNING CLINICS FOR Hamby, Y, JSI Research & Training Institute Donovan, KA, Variable Solutions Region VIII IPP Data Workgroup

Background Region VIII Infertility Prevention Project Chlamydia Reinfection

OBJECTIVES 1.Calculate the incidence of Chlamydia reinfection in women who screened for Chlamydia in Family Planning Clinics in Region VIII over a two year period (2004 and 2005). 2.To determine if women with greater than one visit and positive Chlamydia result has a higher reinfection rate than women with greater than one visit and negative Chlamydia result.

METHODS Analysis was conducted on 93,660 tests performed on women from 2004 to 2005 in Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming. Positivity rates for women with prior positive Chlamydia tests were compared to those from women with prior negative tests.

Records for Analysis 253,876 Records ( ) Exclude Males Exclude Lab 7 Exclude non Family Planning Clinics Exclude Equivocals Records Used for Analysis 93,660

Time since prior visit Project area where patient was tested Unique patient identifier (Soundex Code + DOB) Age Race/Ethnicity Positive at their first visit Negative at their first visit Number of tests Variables Included in the Analysis

Group 1 = +CT result at first visit* and > 1 visit. Group 2 = -CT result at first visit* and > 1 visit. Groups *First visit is the first time appearing in database.

Groups Jan 04 July 04 Jan 05 July 05 Dec 05 Test 1 (+CT) … Test 2 (+CT) Group 1 Test 1 (-CT) … Test 2 (+CT) Group 2 First visit is the first time appearing in database. Test 1 (+/-CT) ………… Test 2 (+/-CT) Not included in analysis

The Incidence Rate is defined as a new case of Chlamydia no earlier than 3 months after the initial result and no later than 9 months after initial results. If the amount of time between initial result and retest is months this is considered an annual visit test. Incidence Definition

Calculated the Risk Ratio for women testing more than once 3-9 months after their first test during Group 1 = +CT result at first visit and > 1 visit. Group 2 = -CT result at first visit and > 1 visit. Incidence of Chlamydia Infection in group 1 (+CT) Risk Ratio = Incidence of Chlamydia Infection in group 2 (-CT) Analysis

State Distribution

RESULTS 13,838 women were tested more than once Graph 1: Age breakdown of women with initial CT infection attending FP clinics and percent second infection, Region VIII IPP,

RESULTS Graph 2: Race/Ethnicity of women with initial CT infection attending FP clinics and percent second infection, Region VIII IPP,

Women who had repeated Chlamydia tests during the study period averaged 2.5 (range=2-9) tests per woman. Graph 3: Number of visits for clients with initial CT infection attending FP clinics and percent second infection, Region VIII IPP, RESULTS

Incidence Rate (-CT) = 0.87 Incidence Rate (+CT) = 3.55 Risk Ratio +CT / -CT = 4.06 RESULTS The incidence of Chlamydia positivity in women with an initial positive Chlamydia test result is 4 times higher than the incidence of Chlamydia positivity in women with an initial negative Chlamydia test result!

Women with an initial +CT result have a Chlamydia positivity rate higher than the CDC goal of 3% or lower.  Overall 2nd infection rate was 23.7% and was higher among: racial/ethnic minorities, women whose first IPP clinic visit was age < 15 years. CONCLUSIONS

Why do women with an initial +CT result have a higher incidence of Chlamydia 3–9 months after their initial test? –Due to untreated partners –Due to the same infection DISCUSSION

Do these data support retesting women for Chlamydia? –Yes – With a Risk Ratio of 4.06 for reinfection, the data support the rescreening of women testing positive for Chlamydia who return for care in FP clinics. When should retest occur? –Based on substantial Chlamydia positivity among women tested less than 10 months from a prior test, rescreening is warranted even if the next visit is within a year of a prior visit. DISCUSSION

Passive follow-up, particularly for women where selective screening criteria included additional measures beyond age, impacts likelihood of re-screening. Substantial variation in visit patterns affects detection of second infections and time to 2nd infection. Only have test records for clients who returned to IPP clinics. Lack data on visits outside IPP. LIMITATIONS

1. Cates W Jr, Brunham RC. Sexually transmitted diseases and infertility. In: Holmes KK, Sparling PF, Mardh P-A, et al., eds. Sexually Transmitted Disease, 3rd ed. New York: McGraw-Hill, 1999; 1079– Hosenfeld CB et al. Repeat Infection With Chlamydia and Gonorrhea Among Females: A systematic Review of the Literature. Sex Transm Dis 2009; 36(8): Hamby Y and Region VIII IPP Data Workgroup. Using the Soundex Function to Track Chlamydia Reinfection Rates in the Region VIII Infertility Prevention Project. National STD Prevention Conference, (Poster) REFERENCES